Dr. Rosenblat is an assistant professor of medicine at Columbia University Medical Center, College of Physicians and Surgeons. He is a hematologist/oncologist with expertise in the diagnosis and treatment of acute and chronic leukemias, myeloproliferative neoplasms, and myelodysplastic syndrome.
His research focuses on development of new and more effective treatments for patients with acute myeloid leukemia. This includes the development of novel drugs and drug combinations, as well as immunotherapy for myeloid leukemias. He received his MD degree from Stony Brook University and completed his fellowship in medical oncology/hematology at Memorial Sloan-Kettering Cancer Center.
Condition | Study Title |
---|---|
Leukemia | [ CLOSED ] Adults with untreated Acute Myeloid Leukemia who are not considered candidates for intensive remission induction using study drug SGI-110 |
Leukemia | [ CLOSED ] A study for patients acute myeloid leukemia or blastic plasmacytoid dendritic cell neoplasm using study drug SL-401 |